Economic Atlas
Companies/Jaguar Health, Inc.
Company profile

Jaguar Health, Inc.

NASDAQ: JAGX · Healthcare · Biotechnology
PublicHQ San Francisco, CA · San FranciscoCIK 0001585608Reports USD
#616 of 1,422 Healthcare companies by revenue39th-percentile growth
EA Score
38D
Revenue TTM
$29.6M
Rev growth YoY (TTM)
+156.0%
Net income (FY)
-$53.6M
Employees
47
as of 2026-08-27
Market cap
$61.4k
as of 2026-08-27

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$11.5M$11.5M2025
Net income-$53.6M-$53.6M2025
Operating income-$45.9M-$45.9M2025
Total assets$38.3M$38.3M2025
Liabilities$57.0M$57.0M2025
Equity-$18.7M-$18.7M2025

Revenue trend

FY2018 – FY2025 · USD
FY18
FY19
FY20
FY22
FY22
FY24
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Mytesi98%
License2%
Neonorm0%
By geography

Not disclosed.

The read

What is Jaguar Health, Inc.’s revenue?

Jaguar Health, Inc. booked $11.5M in FY2025 revenue, contracting 1.5% year over year — slower than 61% of Healthcare companies we track, at a -465.4% net margin.

Peers · Healthcare
Prelude Therapeutics Incorporated37DEscalon Medical Corp.63CBIMI International Medical Inc.——NEXGEL, Inc.51DCaribou Biosciences, Inc.43DBellRock Brands Inc.——
Neighbors
San Francisco →
Visa Inc.$40.0B86AWells Fargo & Company$85.1B55CSalesforce, Inc.$41.5B80B+Uber Technologies, Inc.$52.0B71BPrologis, Inc.$8.8B66BCloudflare, Inc.$2.2B59C
Key facts
CEOLisa A. Conte
SectorHealthcare
IndustryBiotechnology
HeadquartersSan Francisco, CA
ExchangeNASDAQ: JAGX
Employees47
IPO date2015-05-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.